Professor Bridget A. Robinson

2024

Journal - Research Article

Burgess, E. R., Praditi, C., Phillips, E., Vissers, M. C. M., Robinson, B. A., Dachs, G. U., & Wiggins, G. A. R. (2024). Role of sodium-dependent vitamin C transporter-2 and ascorbate in regulating the hypoxic pathway in cultured glioblastoma cells. Journal of Cellular Biochemistry, e30658. Advance online publication. doi: 10.1002/jcb.30658

Topham, B., de Vries, M., Nonis, M., van Berkel, R., Pullar, J. M., Magon, N. J., Vissers, M. C. M., Currie, M. J., Robinson, B. A., Gibbs, D., Ang, A., & Dachs, G. U. (2024). Blood vitamin C levels of patients receiving immunotherapy and relationship to monocyte subtype and epigenetic modification. Epigenomes, 8, 17. doi: 10.3390/epigenomes8020017

2023

Journal - Research Article

de Vries, M., Stewart, T., Ireton, T., Keelan, K., Jordan, J., Robinson, B. A., & Dachs, G. U. (2023). Patients’ and carers’ priorities for cancer research in Aotearoa/New Zealand. PLoS ONE, 18(8), e0290321. doi: 10.1371/journal.pone.0290321

2022

Journal - Research Article

Hakkaart, C., Pearson, J. F., Marquart, L., Dennis, J., Wiggins, G. A. R., Barnes, D. R., Robinson, B. A., Mace, P. D., … Walker, L. C. (2022). Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology, 5, 1061. doi: 10.1038/s42003-022-03978-6

Crake, R. L. I., Burgess, E. R., Wiggins, G. A. R., Magon, N. J., Das, A. B., Vissers, M. C. M., Morrin, H. R., Royds, J. A., Slatter, T. L., Robinson, B. A., Phillips, E., & Dachs, G. U. (2022). Ascorbate content of clinical glioma tissues is related to tumour grade and to global levels of 5-hydroxymethyl cytosine. Scientific Reports, 12, 14845. doi: 10.1038/s41598-022-19032-8

Leong, T. W., McCook, G., Frampton, C. M. A., Robinson, B. A., & James, M. L. (2022). Adjuvant nodal field radiation in resected stage III melanoma: A single-centre retrospective study in Christchurch, New Zealand. Journal of Medical Imaging & Radiation Oncology, 66, 1003-1013. doi: 10.1111/1754-9485.13438

Burgess, E. R., Crake, R. L. I., Phillips, E., Morrin, H. R., Royds, J. A., Slatter, T. L., Wiggins, G. A. R., Vissers, M. C. M., Robinson, B. A., & Dachs, G. U. (2022). Increased ascorbate content of glioblastoma is associated with a suppressed hypoxic response and improved patient survival. Frontiers in Oncology, 12, 829524. doi: 10.3389/fonc.2022.829524

Allen, T., James, M., Frampton, C., Robinson, B., & Withers, N. (2022). Care of seniors with breast cancer: Treatment received and refining decision making. Clinical Oncology, 34, 472-479. doi: 10.1016/j.clon.2022.01.006

2021

Journal - Research Article

Buss, L. A., Hock, B., Merry, T. L., Ang, A. D., Robinson, B. A., Currie, M. J., & Dachs, G. U. (2021). Effect of immune modulation on the skeletal muscle mitochondrial exercise response: An exploratory study in mice with cancer. PLoS ONE, 16(10), e0258831. doi: 10.1371/journal.pone.0258831

Wohlrab, C., Vissers, M. C. M., Burgess, E. R., Nonis, M., Phillips, E., Robinson, B. A., & Dachs, G. U. (2021). Limited association between ascorbate concentrations and vitamin C transporters in renal cell carcinoma cells and clinical samples. Cellular Physiology & Biochemistry, 55, 553-568. doi: 10.33594/000000435

Buss, L. A., Williams, T., Hock, B., Ang, A. D., Robinson, B. A., Currie, M. J., & Dachs, G. U. (2021). Effects of exercise and anti-PD-1 on the tumour microenvironment. Immunology Letters, 239, 60-71. doi: 10.1016/j.imlet.2021.08.005

Crake, R. L. I., Strother, M. R., Phillips, E., Doogue, M. P., Zhang, M., Frampton, C. M. A., Robinson, B. A., & Currie, M. J. (2021). Influence of serum inflammatory cytokines on cytochrome P450 drug metabolising activity during breast cancer chemotherapy: A patient feasibility study. Scientific Reports, 11(1), 5648. doi: 10.1038/s41598-021-85048-1

Dachs, G. U., Gandhi, J., Wohlrab, C., Carr, A. C., Morrin, H. R., Pullar, J. M., Bayer, S. B., Eglinton, T. W., Robinson, B. A., & Vissers, M. C. M. (2021). Vitamin C administration by intravenous infusion increases tumor ascorbate content in patients with colon cancer: A clinical intervention study. Frontiers in Oncology, 10, 600715. doi: 10.3389/fonc.2020.600715

Lattimore, V., Parsons, M. T., Spurdle, A. B., Pearson, J., Lehnert, K., Sullivan, J., … Morrin, H., Robinson, B., & Walker, L. (2021). Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patients. Breast Cancer Research & Treatment, 185, 583-590. doi: 10.1007/s10549-020-05986-8

Journal - Research Other

Buss, L. A., Dachs, G. U., Goddard, L., Ang, A. D., Robinson, B. A., Currie, M. J., & Hock, B. (2021). Is the immunogenicity of PD-1 blocking antibodies a confounding variable in murine studies? Immunology Letters, 234, 13-15. doi: 10.1016/j.imlet.2021.04.003

Conference Contribution - Verbal presentation and other Conference outputs

Robinson, B. (2021, August). The changing face of oncology in NZ. Plenary presentation at the South General Practice Conference & Medical Exhibition (GP CME), [Online].

2020

Journal - Research Article

White, R., Nonis, M., Pearson, J. F., Burgess, E., Morrin, H. R., Pullar, J. M., Spencer, E., Vissers, M. C. M., Robinson, B. A., & Dachs, G. U. (2020). Low vitamin C status in patients with cancer is associated with patient and tumor characteristics. Nutrients, 12(8), 2338. doi: 10.3390/nu12082338

Kain, M., Bennett, H., Yi, M., Robinson, B., & James, M. (2020). 30-day mortality following palliative radiotherapy. Journal of Medical Imaging & Radiation Oncology, 64, 570-579. doi: 10.1111/1754-9485.13073

Mohamad Hanib, M. F. b., Robinson, B. A., Frampton, C., & James, M. L. (2020). Long‐term results from a series of patients managed with breast conservation surgery and hypofractionated radiotherapy in Christchurch: What is the recurrence rate and how do we detect recurrences. Journal of Medical Imaging & Radiation Oncology, 64(6), 852-858. doi: 10.1111/1754-9485.13074

Buss, L. A., Ang, A. D., Hock, B., Robinson, B. A., Currie, M. J., & Dachs, G. U. (2020). Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice. PLoS ONE, 15(3), e0229290. doi: 10.1371/journal.pone.0229290

Patel, V., James, M., Frampton, C., Robinson, B., Davey, V., & Timmings, L. (2020). Body mass index and outcomes in breast cancer treated with breast conservation. International Journal of Radiation Oncology, Biology, Physics, 106(2), 369-376. doi: 10.1016/j.ijrobp.2019.09.049

Richardson, A. K., Walker, L. C., Cox, B., Rollag, H., Robinson, B. A., Morrin, H., Pearson, J. F., … Currie, M. J. (2020). Breast cancer and cytomegalovirus. Clinical & Translational Oncology, 22, 585-602. doi: 10.1007/s12094-019-02164-1

Conference Contribution - Published proceedings: Abstract

Lattimore, V., Parsons, M., Spurdle, A., Pearson, J., Northcott, H., Lehnert, K., … Morrin, H., Robinson, B., & Walker, L. (2020). Potential under-ascertainment of New Zealand women at high-risk of breast cancer in clinical care [Invited]. Proceedings of the Genetics Otago (GO) Zoom Symposium. Retrieved from https://blogs.otago.ac.nz/go/2020-3/

Crake, R., Strother, M., Morrin, H., Smith, A., Phillips, E., Robinson, B., & Currie, M. (2020). An exploratory patient study assessing CYP450 enzyme function in women receiving chemotherapy for breast cancer. New Zealand Medical Journal, 133(1524), (pp. 144). Retrieved from https://www.nzma.org.nz/journal

2019

Journal - Research Article

Whitehead, C., Gerring, R., Frampton, C., Harris, D., & Robinson, B. (2019). Frailty in older patients referred to oncology, and impact of treatment: Use of a modified 6 item score. Clinical Oncology & Research, 2(4), 1-7. doi: 10.31487/j.COR.2019.04.07

Dixit, A., Frampton, C., Davey, V., Robinson, B., & James, M. (2019). Radiation treatment in early stage triple-negative breast cancer in New Zealand: A national database study. Journal of Medical Imaging & Radiation Oncology, 63, 698-706. doi: 10.1111/1754-9485.12933

Wohlrab, C., Kuiper, C., Vissers, M. C. M., Phillips, E., Robinson, B. A., & Dachs, G. U. (2019). Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia, 7, 17-31. doi: 10.2147/hp.S201643

Campbell, E. J., Dachs, G. U., Morrin, H. R., Davey, V., Robinson, B. A., & Vissers, M. C. M. (2019). Activation of the hypoxia pathway in breast cancer tissue and patient survival are inversely associated with tumor ascorbate levels. BMC Cancer, 19, 307. doi: 10.1186/s12885-019-5503-x

Lattimore, V. L., Pearson, J. F., Morley-Bunker, A. E., kConFab Investigators, Spurdle, A. B., Robinson, B. A., Currie, M. J., & Walker, L. C. (2019). Quantifying BRCA1 and BRCA2 mRNA isoform expression levels in single cells. International Journal of Molecular Sciences, 20(3), 693. doi: 10.3390/ijms20030693

James, M., Dixit, A., Robinson, B., Frampton, C., & Davey, V. (2019). Outcomes for patients with non-metastatic triple-negative breast cancer in New Zealand. Clinical Oncology, 31, 17-24. doi: 10.1016/j.clon.2018.09.006

Journal - Research Other

Fischer, J., Walker, L. C., Robinson, B. A., Frizelle, F. A., Church, J. M., & Eglinton, T. W. (2019). Clinical implications of the genetics of sporadic colorectal cancer. ANZ Journal of Surgery, 89(10), 1224-1229. doi: 10.1111/ans.15074

2018

Journal - Research Article

Wohlrab, C., Vissers, M. C. M., Phillips, E., Morrin, H., Robinson, B. A., & Dachs, G. U. (2018). The association between ascorbate and the hypoxia-inducible factors in human renal cell carcinoma requires a functional von Hippel-Lindau protein. Frontiers in Oncology, 8, 574. doi: 10.3389/fonc.2018.00574

Lawrence, B., Blenkiron, C., Parker, K., Tsai, P., Fitzgerald, S., Shields, P., … Black, M., … Robinson, B., … Carroll, R., … Morrin, H., … Jackson, C., … Print, C. (2018). Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer. npj Genomic Medicine, 3, 18. doi: 10.1038/s41525-018-0058-3

Gibbs, P., Heinemann, V., Sharma, N. K., Taieb, J., Ricke, J., Peeters, M., … Robinson, B., Jackson, C., … for the SIRFLOX and FOXFIRE Global Trial Investigators, including Perez, D. (2018). Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy: Combined analysis of two randomized controlled studies. Clinical Colorectal Cancer, 17(4), e617-e629. doi: 10.1016/j.clcc.2018.06.001

Lattimore, V. L., Pearson, J. F., Currie, M. J., Spurdle, A. B., kConFab Investigators, Robinson, B. A., & Walker, L. C. (2018). Investigation of experimental factors that underlie BRCA1/2 mRNA isoform expression variation: Recommendations for utilising targeted RNA sequencing to evaluate potential spliceogenic variants. Frontiers in Oncology, 8, 140. doi: 10.3389/fonc.2018.00140

James, M., Swadi, S., Yi, M., Johansson, L., Robinson, B., & Dixit, A. (2018). Ischaemic heart disease following conventional and hypofractionated radiation treatment in a contemporary breast cancer series. Journal of Medical Imaging & Radiation Oncology, 62(3), 425-431. doi: 10.1111/1754-9485.12712

James, M., McLean, G., Williams, S., Robinson, B., & Yi, M. (2018). Complications of curative radiation treatment for early prostate cancer. Asia-Pacific Journal of Clinical Oncology, 14(5), e392-e398. doi: 10.1111/ajco.12839

Robinson, B., Dijkstra, B., Davey, V., Tomlinson, S., & Frampton, C. (2018). Adherence to adjuvant endocrine therapy in Christchurch women with early breast cancer. Clinical Oncology, 30(1), e9-e15. doi: 10.1016/j.clon.2017.10.015

Buchwald, P., Hall, C., Davidson, C., Dixon, L., Dobbs, B., Robinson, B., & Frizelle, F. (2018). Improved survival for rectal cancer compared to colon cancer: The four cohort study. ANZ Journal of Surgery, 88(3), E114-E117. doi: 10.1111/ans.13730

Conference Contribution - Published proceedings: Abstract

Phillips, E., Kleffmann, T., Morrin, H., Robinson, B., & Currie, M. (2018). Differential secretome analysis of cancer-associated adipocytes (CAA) and mature adipocytes to identify adipocyte-driven micro-environmental regulators of breast cancer progression. ESMO Open, 3(Suppl. 2), (pp. A348). doi: 10.1136/esmoopen-2018-EACR25.820

Wohlrab, C., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2018). Vitamin C transporters in renal cell carcinoma. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Wohlrab, C., Kuiper, C., Vissers, M. C. M., Phillips, E., Robinson, B., & Dachs, G. U. (2018). Ascorbate modulates the hypoxic pathway by increasing activity of HIF hydroxylases. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Crake, R., Strother, M., Morrin, H., Smith, A., Phillips, E., Robinson, B., & Currie, M. (2018). An exploratory breast cancer patient study to assess the impact of obesity-related inflammation and physical activity on chemotherapy drug metabolism. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Lattimore, V., Lehnert, K., Lintott, C., Sullivan, J., Morrin, H., Robinson, B., & Walker, L. (2018). Evaluating variants in breast cancer associated genes identified by panel sequencing of New Zealand breast cancer patients. Proceedings of the New Zealand Society for Oncology (NZSO) Conference. Retrieved from http://www.nzsoncology.org.nz/

Crake, R., Phillips, E., Morrin, H., Strother, M., Robinson, B., & Currie, M. (2018). Transwell co-culture with human breast adipocytes alters the proteome expression profiles of mcf-7 and mda-mb-231 human breast cancer cells. ESMO Open, 3(Suppl. 2), (pp. A111-A112). doi: 10.1136/esmoopen-2018-EACR25.268

Conference Contribution - Poster Presentation (not in published proceedings)

Campbell, E., Dachs, G. U., Morrin, H. R., Davey, V., Robinson, B. A., & Vissers, M. C. M. (2018, August). The regulation of the tumour hypoxic response by ascorbate and association with clinicopathological factors and patient outcome in breast cancer. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Lattimore, V. L., Lehnert, K., Lintott, C., Sullivan, J., Morrin, H., Robinson, B., & Walker, L. C. (2018, August). Evaluating variants in breast cancer associated genes identified by panel sequencing of New Zealand breast cancer patients. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Crake, R., Kleffmann, T., Morrin, H., Strother, M., Robinson, B., Phillips, E., & Currie, M. (2018, August). Cancer-associated adipocytes alter protein expression profiles of human breast cancer cells in vitro. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Crake, R., Strother, M., Morrin, H., Smith, A., Phillips, E., Robinson, B., & Currie, M. (2018, November). An exploratory breast cancer patient study to assess the impact of obesity-related inflammation and physical activity on chemotherapy drug metabolism. Verbal presentation at the Women’s Wellbeing Symposium, Dunedin, New Zealand.

2017

Journal - Research Article

Robinson, B., Currie, M., Phillips, E., Dachs, G., Strother, M., Morrin, H., Davey, V., & Frampton, C. (2017). Body mass index (BMI): Association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand. New Zealand Medical Journal, 130(1451), 46-56. Retrieved from https://www.nzma.org.nz/journal

Fernando, C., Frizelle, F., Wakeman, C., Frampton, C., & Robinson, B. (2017). Colorectal multidisciplinary meeting audit to determine patient benefit. ANZ Journal of Surgery, 87(11), E173-E177. doi: 10.1111/ans.13366

Conference Contribution - Verbal presentation and other Conference outputs

Blenkiron, C., Parker, K., Tsai, P., Fitzgerald, S., Shields, P., Yeong, M. L., … Black, M., … Robinson, B., … Connor, S., Morrin, H., … Lawrence, B. (2017, October). Three distinct genomic landscapes define clinical outcome of pancreatic neuroendocrine tumours (pNETs). Verbal presentation at the 19th Annual Scientific Meeting of the Australasian Gastro-Intestinal Trials Group (AGITG): Trials in Action, Cairns, Australia.

2016

Journal - Research Article

van Hazel, G. A., Heinemann, V., Sharma, N. K., Findlay, M. P. N., Ricke, J., Peeters, M., Perez, D., Robinson, B. A., … Gibbs, P. (2016). SIRFLOX: Randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. Journal of Clinical Oncology, 34(15), 1723-1731. doi: 10.1200/JCO.2015.66.1181

Campbell, E. J., Vissers, M. C. M., Wohlrab, C., Hicks, K. O., Strother, R. M., Bozonet, S. M., Robinson, B. A., & Dachs, G. U. (2016). Pharmacokinetic and anti-cancer properties of high dose ascorbate in solid tumours of ascorbate-dependent mice. Free Radical Biology & Medicine, 99, 451-462. doi: 10.1016/j.freeradbiomed.2016.08.027

James, M. L., Dehn, G., & Robinson, B. A. (2016). Hypofractionated radiation treatment in early breast cancer: Results in a New Zealand setting. Asia-Pacific Journal of Clinical Oncology, 12, 248-253. doi: 10.1111/ajco.12458

Journal - Research Other

Young, A., Marshall, E., Kryzanowska, M., Robinson, B., Brown, S., Collinson, F., … Selby, P. (2016). Responding to acute care needs of patients with cancer: Recent trends across continents. Oncologist, 21(3), 301-307. doi: 10.1634/theoncologist.2014-0341

Conference Contribution - Published proceedings: Abstract

Campbell, E., Vissers, M., Wohlrab, C., Hicks, K., Strother, M., Robinson, B., Bozonet, S., & Dachs, G. (2016). High-dose ascorbate administration increases tumor ascorbate levels and decreases hypoxia-inducible factor-1 activity and tumor growth in mice. Free Radical Biology & Medicine, 100(Suppl.), (pp. S132). doi: 10.1016/j.freeradbiomed.2016.10.346

Vissers, M. C. M., Campbell, E. J., Kuiper, C., Carr, A. C., Wohlrab, C., Bozonet, S. M., Morrin, H., Robinson, B. A., & Dachs, G. U. (2016). Ascorbate as an anti-cancer therapy? Investigations into feasibility and potential mechanism of action. Proceedings of the Diagnostics, Drugs, Devices, Discovery (D4) Conference. Retrieved from http://www.otago.ac.nz/d4/index.html

2015

Journal - Research Article

Price, T. J., Bruhn, M. A., Lee, C. K., Hardingham, J. E., Townsend, A. R., Mann, K. P., … Robinson, B., … Tebbutt, N. C. (2015). Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX study involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer. British Journal of Cancer, 112, 963-970. doi: 10.1038/bjc.2015.37

Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., … kConFab, including George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Easton, D. F. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Geoscience, 47, 373-380. doi: 10.1038/ng.3242

Kuchenbaecker, K. B., Ramus, S. J., Tyrer, J., Lee, A., Shen, H. C., Beesley, J., … kConFab, including George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … for the Consortium of Investigators of Modifiers of BRCA1 and BRCA2. (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics, 47(2), 164-171. doi: 10.1038/ng.3185

Dachs, G. U., Phillips, E., Phung, Y., Dyer, A., Willis, J. A., Currie, M. J., & Robinson, B. A. (2015). Tumour growth in mice resistant to diet-induced obesity. Journal of Molecular Biochemistry, 4(2), 42-49.

Gerring, Z., Pearson, J. F., Morrin, H. R., Robinson, B. A., Harris, G. C., & Walker, L. C. (2015). Phosphohistone H3 outperforms Ki67 as a marker of outcome for breast cancer patients. Histopathology, 67(4), 538-547. doi: 10.1111/his.12678

Richardson, A. K., Currie, M. J., Robinson, B. A., Morrin, H., Phung, Y., Pearson, J. F., … Walker, L. C. (2015). Cytomegalovirus and Epstein-Barr Virus in breast cancer. PLoS ONE, 10(2), e0118989. doi: 10.1371/journal.pone.0118989

Campbell, E. J., Vissers, M. C. M., Bozonet, S., Dyer, A., Robinson, B. A., & Dachs, G. U. (2015). Restoring physiological levels of ascorbate slows tumor growth and moderates HIF-1 pathway activity in Gulo^−/− mice. Cancer Medicine, 4(2), 303-314. doi: 10.1002/cam4.349

Ko, D.-H. I., Norriss, A., Harrington, C. R., Robinson, B. A., & James, M. L. (2015). Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience. Journal of Medical Imaging & Radiation Oncology, 59, 243-247. doi: 10.1111/1754-9485.12242

Journal - Research Other

Lattimore, V., Currie, M., Lintott, C., Sullivan, J., Robinson, B. A., & Walker, L. C. (2015). Meeting the challenges of interpreting variants of unknown clinical significance in BRCA testing. New Zealand Medical Journal, 128(1419). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Lattimore, V., Pearson, J., Currie, M., Robinson, B., & Walker, L. (2015). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. New Zealand Medical Journal, 128(1421). Retrieved from https://www.nzma.org.nz/journal

Ferdinand, S., Peters, S., Mulligan, H., & Robinson, B. (2015). Development and piloting of an exercise program for prostate cancer survivors using stakeholder engagement. Physiotherapy, 101(Suppl. 1), (pp. e379-e380). doi: 10.1016/j.physio.2015.03.599

Conference Contribution - Poster Presentation (not in published proceedings)

Ernst, C., Phillips, E., Morrin, H., Vissers, M., Robinson, B., & Dachs, G. (2015, October). The role of ascorbate in controlling hypoxia factors in renal cell carcinoma. Poster session presented at the Otago Spotlight Series: Cancer Research, Wellington, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Lattimore, V., Pearson, J. F., Currie, M., Robinson, B. A., Spurdle, A. B., & Walker, L. C. (2015, August-September). Using splicing assays to interpret variants of unknown clinical significance in BRCA1 and BRCA2. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Robinson, B. (2015, August). GP support for patients on chemotherapy, hormones and other targeted therapies. Workshop presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

Robinson, B. (2015, August). Modern chemotherapy and hormone therapy for breast cancer. Plenary presentation at the South General Practice Conference & Medical Exhibition (GP CME), Christchurch, New Zealand.

2014

Chapter in Book - Research

Robinson, B. (2014). Managing acute issues in oncology in Australasia. In E. Marshall, A. Young, P. I. Clark & P. Selby (Eds.), Problem solving in acute oncology. (pp. 50-55). Oxford, UK: Atlas Medical Publishing.

Journal - Research Article

Valle, J. W., Palmer, D., Jackson, R., Cox, T., Neoptolemos, J. P., Ghaneh, P., … Robinson, B. A., … Büchler, M. W. (2014). Optimal duration and timing of adjuvant chemotherapy after definitive surgery for ductal adenocarcinoma of the pancreas: Ongoing lessons from the ESPAC-3 study. Journal of Clinical Oncology, 32, 504-512. doi: 10.1200/JCO.2013.50.7657

Perry, J. R. B., Day, F., Elks, C. E., Sulem, P., Thompson, D. J., Ferreira, T., … kConFab, including George, P., Kidd, A., Reeve, T., Robinson, B., Walker, L., … Ong, K. K. (2014). Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature, 514, 92-97. doi: 10.1038/nature13545

Jackson, C. G. C. A., Sharples, K., Thompson, P. I., O'Donnell, A., Robinson, B. A., Perez, D. J., … Findlay, M. P. (2014). Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: A multi-centre phase II study. BMC Cancer, 14, 737. doi: 10.1186/1471-2407-14-737

Davey, V. C. L., Harris, G., Dijkstra, B., James, M., & Robinson, B. (2014). A review of the Christchurch Hospital Breast Cancer Service in 2012: Meeting the new Tumour Standards. New Zealand Medical Journal, 127(1399). Retrieved from http://www.nzma.org.nz/journal

Kuiper, C., Dachs, G. U., Munn, D., Currie, M. J., Robinson, B. A., Pearson, J. F., & Vissers, M. C. M. (2014). Increased tumour ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in human colorectal cancer. Frontiers in Oncology, 4, 10. doi: 10.3389/fonc.2014.00010

Volkova, E., Robinson, B. A., Willis, J., Currie, M. J., & Dachs, G. U. (2014). Marginal effects of glucose, insulin and insulin-like growth factor on chemotherapy response in endothelial and colorectal cancer cells. Oncology Letters, 7(2), 311-320. doi: 10.3892/ol.2013.1710

Journal - Research Other

Jackson, C., Robinson, B., & Findlay, M. (2014). Cancer services to 2025 in New Zealand: Investing in research-driven quality care. New Zealand Medical Journal, 127(1395). Retrieved from http://www.nzma.org.nz/journal

Dachs, G. U., Munn, D. G., Carr, A. C., Vissers, M. C. M., & Robinson, B. A. (2014). Consumption of vitamin C is below recommended daily intake in many cancer patients and healthy volunteers in Christchurch. New Zealand Medical Journal, 127(1390). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Campbell, E. J., Bozonet, S. M., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2014). Restoring physiological levels of ascorbate alleviates HIF-1 activation and reduces tumour growth in Gulo^-/- mice. Proceedings of the American Association for Cancer Research (AACR) 105th Annual Meeting. Retrieved from http://www.aacr.org/home/scientists/meetings--workshops/aacr-annual-meeting-2014.aspx

Conference Contribution - Poster Presentation (not in published proceedings)

Campbell, E. J., Bozonet, S., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2014, August). Pharmacokinetic and anti-cancer properties of high dose vitamin C in tumour bearing Gulo^-/- mice. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, & Walker, L. (2014, September). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Learning Different Research Languages, Dunedin, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Rahman, A., Winter, A., DeRyke, R., Fenwick, J., Griffin, N., Frampton, C., Smith, M., Currie, M., & Robinson, B. (2014, October). Venous thromboembolism in cancer patients undertaking chemotherapy. Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Tauranga, New Zealand.

Robinson, B. (2014, October). Systemic adjuvant therapy offered and received by women with early breast cancer in Christchurch during 2012: A report from the Christchurch Breast Cancer Register. Verbal presentation at the New Zealand Society for Oncology (NZSO) Conference, Tauranga, New Zealand.

2013

Chapter in Book - Other

Robinson, B. (2013). Mackenzie Cancer Research Group. In P. Joyce, G. Nicholls, K. Thomas & T. Wilkinson (Eds.), The Christchurch experience: 40 years of research and teaching. (pp. 105-108). Christchurch, New Zealand: University of Otago.

Journal - Research Article

Lim, M., Sharma, P., Ing, A., Blackburne, H., Robinson, B., Dixon, L., Frampton, C., & Frizelle, F. (2013). Continued progress with stage III colorectal cancer: A triple cohort study. New Zealand Medical Journal, 126(1382). Retrieved from http://www.nzma.org.nz/journal

Morrin, H. R., & Robinson, B. A. (2013). Sustaining a biobank through a series of earthquake swarms: Lessons learned from our New Zealand experience. Biopreservation & Biobanking, 11(4), 211-215. doi: 10.1089/bio.2013.0033

Walker, L. C., McDonald, M., Wells, J. E., Harris, G. C., Robinson, B. A., & Morris, C. M. (2013). Dual-color fluorescence in situ hybridization reveals an association of chromosome 8q22 but not 8p21 imbalance with high grade invasive breast carcinoma. PLoS ONE, 8(7), e70790. doi: 10.1371/journal.pone.0070790

Edwards, A. L., Gunningham, S. P., Clare, G. C., Hayman, M. W., Smith, M., Frampton, C. M. A., Robinson, B. A., Troughton, R. W., & Beckert, L. E. L. (2013). Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension. Respirology, 18(8), 1271-1277. doi: 10.1111/resp.12152

Bidwell, S., Simpson, A., Sullivan, R., Robinson, B., Thomas, W., Jackson, C., … Clarke, T. (2013). A workforce survey of New Zealand medical oncologists. New Zealand Medical Journal, 126(1371). Retrieved from http://www.nzma.org.nz/journal

Currie, M. J., Beardsley, B. E., Harris, G. C., Gunningham, S. P., Dachs, G. U., Dijkstra, B., Morrin, H. R., Wells, J. E., & Robinson, B. A. (2013). Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: Relationships with markers of tumor hypoxia and microvascularity. Human Pathology, 44(3), 402-411. doi: 10.1016/j.humpath.2012.06.004

Journal - Research Other

Jackson, C., McCall, J., Robinson, B., Sharples, K., & Findlay, M. (2013). Cancer trials in New Zealand: Patients are not the problem. New Zealand Medical Journal, 126(1381). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Published proceedings: Abstract

Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, Spurdle, A., & Walker, L. (2013). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. New Zealand Medical Journal, 126(1375). Retrieved from http://www.nzma.org.nz/journal

Campbell, E. J., Dyer, A., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2013). The impact of physiological levels of vitamin C on tumour growth and HIF-1 activation in the Gulo ^-/- mouse. New Zealand Medical Journal, 126(1375). Retrieved from http://www.nzma.org.nz/journal

Conference Contribution - Poster Presentation (not in published proceedings)

Lattimore, V., Currie, M., Robinson, B., kConFab Investigators, Spurdle, A., & Walker, L. (2013, September). Elevating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Foundations for Health: Otago Health Research, Christchurch, New Zealand.

Kuiper, C., Dachs, G. U., Munn, D., Currie, M. J., Robinson, B. A., Pearson, J. F., & Vissers, M. C. M. (2013, August). Increased tumour ascorbate is associated with extended disease-free survival and decreased hypoxia-inducible factor-1 activation in patients with colorectal cancer. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Campbell, E. J., Dyer, A., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2013, August). The effect of dietary ascorbate levels on tumour growth and HIF-1 activation in the Gulo^-/- mouse. Verbal presentation at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

Robinson, B. (2013, February). Keeping cancer research close to the patient. Verbal presentation at the Christchurch Medical School 40th Anniversary Celebrations, Christchurch, New Zealand.

Other Research Output

Robinson, B. (2013, April). Advances in cancer medicine: Pathways. University of Otago Christchurch Health Lecture Series. Christchurch, New Zealand. [Public Seminar].

2012

Journal - Research Article

Davey, V., Robinson, B., Dijkstra, B., & Harris, G. (2012). The Christchurch Breast Cancer Patient Register: The first year. New Zealand Medical Journal, 125(1360). Retrieved from http://www.nzma.org.nz/journal

Price, T. J., Zannino, D., Wilson, K., Simes, R. J., Cassidy, J., van Hazel, G. A., Robinson, B. A., … Tebbutt, N. C. (2012). Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: A subgroup analysis from the AGITG MAX trial: An international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C. Annals of Oncology, 23(6), 1531-1536. doi: 10.1093/annonc/mdr488

Hock, B. D., Mackenzie, K. A., Cross, N. B., Taylor, K. G., Currie, M. J., Robinson, B. A., Simcock, J. W., & McKenzie, J. L. (2012). Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells. Nephrology Dialysis Transplantation, 27(1), 402-410. doi: 10.1093/ndt/gfr264

Hunt, M. A., Li, D., Hay, M. P., Currie, M. J., Robinson, B. A., Patterson, A. V., & Dachs, G. U. (2012). Characterisation of enzyme prodrug gene therapy combinations in coated spheroids and vascular networks in vitro. Journal of Gene Medicine, 14(1), 62-74. doi: 10.1002/jgm.1635

Conference Contribution - Published proceedings: Abstract

Ing, A., Blackburne, H., Dobbs, B., Wakeman, C., Robinson, B., & Frizelle, F. (2012). Colorectal cancer a review of treatment and survival. ANZ Journal of Surgery, 82(Suppl. 1), (pp. 34). doi: 10.1111/j.1445-2197.2012.06054.x

Rahman, A. H. B., Waghorn, R. H., Patterson, D. M., Denholm, A., Gunningham, S. P., Currie, M. J., Frampton, C. M. A., Smith, M. P., & Robinson, B. A. (2012). The effect of malignancy and chemotherapy on thrombin generation in cancer patients. Thrombosis Research, 129(Suppl. 1), (pp. S187). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Lattimore, V., Robinson, B., Currie, M., & Walker, L. (2012, September). Evaluating BRCA1 and BRCA2 sequence variants that modulate isoform expression. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Campbell, E. J., Dyer, A., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2012, September). The impact of physiological levels of vitamin C on tumour growth in gulo-/- mice. Poster session presented at the Division of Health Sciences Research Forum: Health Matters: Research Excellence at Otago, Dunedin, New Zealand.

Campbell, E. J., Dyer, A., Robinson, B. A., Vissers, M. C. M., & Dachs, G. U. (2012, August). The impact of physiological levels of vitamin C on tumour growth in Gulo-/-mice. Poster session presented at the Queenstown Molecular Biology (QMB) Meetings, Queenstown, New Zealand.

2011

Journal - Research Article

Zhi, J., Chen, E., Major, P., Burns, I., Robinson, B., McKendrick, J., … Goldstein, D. (2011). A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer. Cancer Chemotherapy & Pharmacology, 68(5), 1199-1206. doi: 10.1007/s00280-011-1606-z

MacKenzie, K. A., Miller, A. P., Hock, B. D., Gardner, J., Simcock, J. W., Roake, J. A., Dachs, G. U., Robinson, B. A., & Currie, M. J. (2011). Angiogenesis and host immune response contribute to the aggressive character of non-melanoma skin cancers in renal transplant recipients. Histopathology, 58(6), 875-885. doi: 10.1111/j.1365-2559.2011.03845.x

Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011). Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. British Journal of Cancer, 104, 51-59. doi: 10.1038/sj.bjc.6606005

Conference Contribution - Published proceedings: Abstract

Price, T. J., Zannino, D., Wilson, K., Simes, J., van Hazel, G. A., Robinson, B. A., … Tebbutt, N. C. (2011). Geriatric subgroup of AGITG MAX trial: International randomized phase III trial of capecitabine (C), bevacizumab (B), and mitomycin C (M) in first-line metastatic colorectal cancer (CRC). Journal of Clinical Oncology, 29(Suppl. 4), 510. Retrieved from http://www.asco.org

Price, T. J., Zannino, D., Wilson, K., Simes, J., van Hazel, G. A., Robinson, B. A., … Tebbutt, N. C. (2011). Outcome and dose intensity (DI) in the elderly subgroup of the AGITG MAX phase III trial of capecitabine (C), bevacizumab (B), and mitomycin C (M) in first-line metastatic colorectal cancer (CRC). Journal of Clinical Oncology, 29(Suppl. 15), 3621. [Abstract]

2010

Journal - Research Article

Dachs, G. U., Kano, M., Volkova, E., Morrin, H. R., Davey, V. C. L., Harris, G. C., … Frampton, C., Currie, M. J., Wells, J. E., & Robinson, B. A. (2010). A profile of prognostic and molecular factors in European and Māori breast cancer patients. BMC Cancer, 10, 543. doi: 10.1186/1471-2407-10-543

Hunt, M. A., Currie, M. J., Robinson, B. A., & Dachs, G. U. (2010). Optimizing transfection of primary human umbilical vein endothelial cells using commercially available chemical transfection reagents. Journal of Biomolecular Techniques, 21, 66-72.

Tebbutt, N. C., Wilson, K., Gebski, V. J., Cummins, M. M., Zannino, D., van Hazel, G. A., Robinson, B., … Price, T. J. (2010). Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastic colorectal cancer: Results of the Australasian Gastrointestinal Trials Group randomized phase III MAX study. Journal of Clinical Oncology, 28(19), 3191-3198. doi: 10.1200/JCO.2009.27.7723

Mackenzie, K. A., Wells, J. E., Lynn, K. L., Simcock, J. W., Robinson, B. A., Roake, J. A., & Currie, M. J. (2010). First and subsequent nonmelanoma skin cancers: Incidence and predictors in a population of New Zealand renal transplant recipients. Nephrology Dialysis Transplantation, 25, 300-306. doi: 10.1093/ndt/gfp482

Journal - Research Other

Robinson, B. (2010). [Review of the book Ethical issues in governing biobanks: Global perspectives]. New Zealand Medical Journal, 123(1327). Retrieved from http://journal.nzma.org.nz/journal/123-1327/4490/content.pdf

Conference Contribution - Verbal presentation and other Conference outputs

Robinson, B. (2010, September). Keeping cancer research close to the patient. Verbal presentation at the Fourth Annual Division of Health Sciences Research Forum, Dunedin, New Zealand.

Robinson, B. (2010, May). Tissue banking in New Zealand: The experiences of the Christchurch Cancer Society Tissue Bank. Verbal presentation at the New Zealand Society for Oncology (NZSO) Annual Meeting, Auckland, New Zealand.

2009

Journal - Research Article

Chin, P. K. L., Beckert, L. E. L., Gunningham, S., Edwards, A. L., & Robinson, B. A. (2009). Audit of anticoagulant thromboprophylaxis in hospitalized oncology patients. Internal Medicine Journal, 39(12), 819-825. doi: 10.1111/j.1445-5994.2008.01828.x

Conference Contribution - Published proceedings: Abstract

Dachs, G. U., Hunt, M., Patterson, A. V., Ackerley, D., Currie, M. J., & Robinson, B. A. (2009). Vascular targeted gene therapy of cancer. Journal of Vascular Research, 46(Suppl. 2), (pp. 18). doi: 10.1159/000230992

Volkova, E., Willis, J., Robinson, B., Dachs, G., & Currie, M. (2009). Obesity and tumour angiogenesis in colon cancer. Journal of Vascular Research, 46(Suppl. 2), (pp. 17). doi: 10.1159/000230992

Tebbutt, N. C., Gebski, V., Wilson, K., Cummins, M., Chua, Y., Robinson, B., … Price, T. (2009). International randomized phase III study of capecitabine (Cap), bevacizumab (Bev), and mitomycin C (MMC) in first-line metastatic colorectal cancer (mCRC): Final results of the AGITG MAX trial. Journal of Clinical Oncology, 27(Suppl. 15), 4023. [Abstract]

Hunt, M., Keown, D., Patterson, A., Currie, M., Robinson, B., & Dachs, G. (2009). Novel prodrugs for enzyme prodrug gene therapy against tumor endothelium. Proceedings of the American Association for Cancer Research (AACR) 100th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Volkova, E., Willis, J. A., Gunningham, S. P., Hanrahan, V., Pearson, J., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2009). Role of obesity in colon tumor angiogenesis and cancer progression. Proceedings of the American Association for Cancer Research (AACR) 100th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

MacKenzie, K. A., Wells, E., Currie, M., Simcock, J., Lynn, K., & Robinson, B. (2009). Incidence and subsequent non-melanoma skin cancers in Canterbury renal transplant recipients: What can we learn? ANZ Journal of Surgery, 79(Suppl. 1), (pp. A56). doi: 10.1111/j.1445-2197.2009.04927.x

Conference Contribution - Poster Presentation (not in published proceedings)

Hunt, M. A., Keown, D. A., Patterson, A. V., Currie, M. J., Robinson, B. A., & Dachs, G. U. (2009, September). Novel prodrugs for enzyme prodrug gene therapy against tumour endothelium. Poster session presented at the Third Annual Division of Health Sciences Research Forum, Wellington, New Zealand.

2008

Journal - Research Article

Dachs, G. U., Currie, M. J., Mckenzie, F., Jeffreys, M., Cox, B., Foliaki, S., … Robinson, B. A. (2008). Cancer disparities in indigenous Polynesian populations: Māori, Native Hawaiians, and Pacific people. Lancet Oncology, 9(5), 473-484. doi: 10.1016/S1470-2045(08)70127-X

Walker, L. C., Harris, G. C., Wells, J. E., Robinson, B. A., & Morris, C. M. (2008). Association of chromosome band 8q22 copy number gain with high grade invasive breast carcinomas by assessment of core needle biopsies. Genes Chromosomes & Cancer, 47(5), 405-417. doi: 10.1002/gcc.20545

Conference Contribution - Published proceedings: Abstract

Stockler, M. R., Grimison, P. S., Price, T. J., van Hazel, G. A., Robinson, B. A., Broad, A., … Australasian Gastro-Intestinal Trials Group (AGITG). (2008). Comparing utilities for advanced colorectal cancer valued from societal and cancer patients' perspectives using baseline data from the MAX study. Journal of Clinical Oncology, 26(Suppl. 15), 6504. [Abstract]

Price, T. J., Gebski, V., van Hazel, G., Robinson, B., Broad, A., Ganju, V., … Tebbutt, N. (2008). AGITG MAX Trial: Capecitabine (Cap), bevacizumab (Bev), and mitomycin C (MMC) in metastatic colorectal cancer (mCRC): Safety analysis of 400 patients in an international multi-centre randomized phase II/III study. Proceedings of the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium. Retrieved from http://www.asco.org

Price, T. J., Gebski, V., van Hazel, G. A., Robinson, B. A., Broad, A., Ganju, V., … Tebbutt, N. C. (2008). International multi-centre randomised phase II/III study of capecitabine (Cap), bevacizumab (Bev) and mitomycin C (MMC) as first-line treatment for metastatic colorectal cancer (mCRC): Final safety analysis of the AGITG MAX trial. Journal of Clinical Oncology, 26(Suppl. 15), 4029. [Abstract]

Morrin, H., Gunningham, S., Currie, M., Dachs, G., Fox, S., & Robinson, B. (2008). Cancer Society Tissue Bank (CSTB) New Zealand: The increasing importance of supplementary sample banking for breast cancer research. Cell Preservation Technology, 6(2), (pp. 157). doi: 10.1089/cpt.2008.9998

Mead, S., Chong, A., Robinson, B., & George, P. (2008). Genetics analysis of cancer patients with 5-Flurouricil toxicity. Proceedings of the 4th Annual Carney Pharmacogenomics Symposium. Retrieved from http://www.chmeds.ac.nz/research/carneycentre/symposium.htm

Kano, M., Volkova, E., Harris, G. C., Morrin, H. R., Cheale, M., Frampton, C., Wells, E., Robinson, B. A., Currie, M. J., & Dachs, G. U. (2008). A comparison of patient, tumour and circulating factors in breast cancer patients of different ethnicities in New Zealand. Proceedings of the American Association for Cancer Research (AACR) 99th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Gunningham, S. P., Lai, C.-Y., Currie, M. J., Hanrahan, V., Lambie, N., Cameron, V. A., Robinson, B. A., & Fox, S. B. (2008). The angiogenic receptor neuropilin-1 is associated with tumor stage and lymph node status in colorectal cancer. Proceedings of the American Association for Cancer Research (AACR) 99th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Hunt, M. A., Dachs, G. U., Currie, M. J., Patterson, A. V., & Robinson, B. A. (2008). Vessel directed enzyme-prodrug therapy for cancer. New Zealand Medical Journal, 121(1271). Retrieved from http://journal.nzma.org.nz/journal/121-1271/2990/content.pdf

Findlay, M. P., Sharples, K. J., Thompson, P. I., Perez, D. J., Adams, J., Isaacs, R., Robinson, B., … O'Donnell, A. E. (2008). A phase II study of Capecitabine (C), Oxaliplatin (O) and Bevacizumab (B) using a 2-weekly schedule in previously untreated patients (PTS) with advanced, unresectable colorectal cancer (CRC): Cancer Trials New Zealand Study 05-6. Annals of Oncology, 19(Suppl. 8), (pp. viii129-viii130). doi: 10.1093/annonc/mdn507

Conference Contribution - Poster Presentation (not in published proceedings)

Moran, S., McDonald, M., Harris, G., Robinson, B., & Morris, C. (2008, August-September). FISHing for ERBB2 (HER-2) gene amplification in breast cancer: An evaluation of alternative methodologies. Poster session presented at the Queenstown Molecular Biology Meetings, Queenstown, New Zealand.

2007

Journal - Research Article

Kuebler, J. P., Colangelo, L., O'Connell, M. J., Smith, R. E., Yothers, G., Begovic, M., Robinson, B., … Wolmark, N. (2007). Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin. Cancer, 110(9), 1945-1950. doi: 10.1002/cncr.23013

Easton, D. F., Pooley, K. A., Dunning, A. M., Pharoah, P. D. P., Thompson, D., Ballinger, D. G., … McCredie, M., … and also Fleming, J., George, P., Reeve, T., & Robinson, B. (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447, 1087-1095. doi: 10.1038/nature05887

Gunningham, S. P., Currie, M. J., Morrin, H. R., Tan, E. Y., Turley, H., Dachs, G. U., Watson, A. I., Frampton, C., Robinson, B. A., & Fox, S. B. (2007). The angiogenic factor thymidine phosphorylase up-regulates the cell adhesion molecule P-selectin in human vascular endothelial cells and is asociated with P-selectin expression in breast cancers. Journal of Pathology, 212, 335-344.

Walker, L. C., Harris, G. C., Holloway, A. J., McKenzie, G. W., Wells, J. E., Robinson, B. A., & Morris, C. M. (2007). Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast. Cancer Genetics & Cytogenetics, 178, 94-103.

Conference Contribution - Published proceedings: Abstract

Gunningham, S., Currie, M., Hanrahan, V., Dachs, G., Morrin, H., Frampton, C., Robinson, B., & Fox, S. (2007). The short mRNA isoform of vascular endothelial growth factor receptor-3 (VEGFR-3) is down-regulated by estrogen and progesterone in breast cancer. Proceedings of the American Association for Cancer Research (AACR) 98th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

2006

Journal - Research Article

Harvey, V., Mouridsen, H., Semiglazov, V., Jakobsen, E., Voznyi, E., Robinson, B. A., … Cold, S. (2006). Phase III trial comparing three doses of docetaxel for second-line treatment of advanced breast cancer. Journal of Clinical Oncology, 24(31), 4963-4970.

Dachs, G. U., Steele, A. J., Coralli, C., Kanthou, C., Brooks, A. C., Gunningham, S. P., Currie, M. J., Watson, A. I., Robinson, B. A., & Tozer, G. M. (2006). Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-I and gene expression. BMC Cancer, 6, 280. doi: 10.1186/1471-2407-6-280

Roberts, R. L., Gearry, R. B., Allington, M. D. E., Morrin, H. R., Robinson, B. A., & Frizelle, F. A. (2006). Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Research, 66(5), 2532-2535.

Conference Contribution - Published proceedings: Abstract

Currie, M. J., Hanrahan, V., Gunningham, S. P., Morrin, H. R., Dachs, G. U., Frampton, C., Fox, S. B., & Robinson, B. A. (2006). Increased Ang1 and Tie2 gene expression is associated with survival in colorectal cancer patients. Proceedings of the American Association for Cancer Research (AACR) 97th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Morrin, H. R., Gunningham, S. P., Currie, M. J., Dachs, G. U., Fox, S. B., & Robinson, B. A. (2006). The Christchurch Tissue Bank: A biorepository for cancer research. New Zealand Medical Journal, 119(1231). Retrieved from http://journal.nzma.org.nz/journal/119-1231/1922/content.pdf

Dachs, G. U., Watson, A. I., Currie, M. J., Gunningham, S. P., Tupper, J., & Robinson, B. A. (2006). Using gene therapy to activate paracetemol for anti-vascular treatment of cancer. New Zealand Medical Journal, 119(1231). Retrieved from http://journal.nzma.org.nz/journal/119-1231/1922/content.pdf

Walker, L. C., Harris, G. C., Holloway, A. J., McKenzie, G. W., Robinson, B. A., & Morris, C. M. (2006). KRT8/18 expression differentiates distinct molecular subtypes of grade 3 invasive ductal carcinomas. In L. Griffiths (Ed.), Proceedings of the 11th International Congress of Human Genetics. (pp. 155). [Abstract]

2005

Journal - Research Article

Currie, M. J., Hanrahan, V., Gunningham, S. P., Morrin, H. R., Frampton, C., Han, C., Robinson, B. A., & Fox, S. B. (2005). Expression of HIF-1α in human tumours. Journal of Clinical Pathology, 58, 335-336.

Morrin, H., Gunningham, S., Currie, M., Dachs, G., Fox, S., & Robinson, B. (2005). The Christchurch Tissue Bank to support cancer research. New Zealand Medical Journal, 118(1225). Retrieved from http://journal.nzma.org.nz/journal/118-1225/1735/content.pdf

Hillock, R., Lainchbury, J., & Robinson, B. (2005). Cardiac angiosarcoma: Diagnosis by coronary angiography. Heart, 91(1270). Retrieved from http://heart.bmjjournals.com/cgi/content/full/91/10/1270

Robinson, B., Frizelle, F., Dickson, M., & Frampton, C. (2005). Colorectal cancer treated at Christchurch Hospital, New Zealand: A comparison of 1993 and 1998 cohorts. New Zealand Medical Journal, 118(1210). Retrieved from http://journal.nzma.org.nz/journal/118-1210/1323/content.pdf

Conference Contribution - Published proceedings: Abstract

Gunningham, S. P., Currie, M. J., Morrin, H. R., Dachs, G. U., Scott, P. A. E., Frampton, C. M., Robinson, B. A., & Fox, S. B. (2005). The angiogenic factor thymidine phosphorylase upregulates the cell adhesion factor p-selectin in human endothelial cells. Proceedings of the American Association for Cancer Research (AACR) 96th Annual Meeting. Retrieved from http://www.aacrmeetingabstracts.org/

Conference Contribution - Verbal presentation and other Conference outputs

Morris, C. M., Walker, L. C., McKenzie, G. C., & Robinson, B. A. (2005, August). Breast cancer genetics. Verbal presentation at the NZ Institute of Medical Laboratory Science Annual Scientific Meeting NZ Society of Cytology 36th Annual Conference, Christchurch, New Zealand.

Walker, L. C., Harris, G. C., McKenzie, G. W., Clark, M., Robinson, B. A., & Morris, C. M. (2005, May). Molecular sub-classification of invasive ductal carcinoma of no special type. Verbal presentation at the New Zealand Society for Oncology Conference, Wellington, New Zealand.

Walker, L. C., Harris, G. C., McKenzie, G. W., Robinson, B. A., & Morris, C. M. (2005, December). Molecular sub-classification of breast cancer. Verbal presentation at the Human Genetics Society of Australasia (NZ Branch) Biennial Scientific Meeting, Christchurch, New Zealand.

2004

Journal - Research Article

Currie, M., Hanrahan, V., Gunningham, S. P., Morrin, H. R., Frampton, C., Han, C., Robinson, B. A., & Fox, S. B. (2004). Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1α) and the HIF-1α target gene DEC1, but not lymph node metastasis in primary human breast carcinomas. Journal of Clinical Pathology, 57, 829-834.

Jardine, D. L., Krediet, C. T. P., & Robinson, B. A. (2004). Baroreflex failure secondary to paraneoplastic encephalomyelitis in a 17 year old woman with neuroblastoma. Journal of Neurology, Neurosurgery & Psychiatry, 75, 1650-1651.

Conference Contribution - Published proceedings: Abstract

Robinson, B., Brunton, H., Morris, C., Mercer, P., & Atkinson, C. (2004). The Christchurch breast cancer database: The first report. Proceedings of the Canterbury Health Science Research Conference. (pp. 35). [Abstract]

Morris, C., Walker, L., Wells, E., Brunton, H., Atkinson, C., & Robinson, B. (2004). Molecular profiling breast carcinomas by comparative genomic hybridization of prospectively sampled core biopsies. Proceedings of the 95th Annual Meeting of the American Association for Cancer Research. 45(A5269). [Abstract]

Morris, C., Walker, L., McKenzie, G., Harris, G., Miller, A., Morrin, H., … Wells, E., Atkinson, C., & Robinson, B. (2004). Cytogenetic and molecular profiling of breast cancer. Proceedings of the Canterbury Health Science Research Conference. (pp. 30). [Abstract]

Robinson, B., Brunton, H., Morris, C., Mercer, P., & Atkinson, C. (2004). The Christchurch breast cancer database: The first report. Proceedings of the New Zealand Society for Oncology Conference. (pp. 53). [Abstract]

Morris, C., Benjes, S., Gough, S., McDonald, M., McKenzie, G., Moon, S. Y., Walker, L., Morrin, H., … Atkinson, C., Ganly, P., Harris, G., Miller, A., Robinson, B., & Spearing, R. (2004). Cancer genetics: Ar'ray for the future! Proceedings of the New Zealand Society for Oncology Conference. (pp. 30). [Abstract]

Conference Contribution - Poster Presentation (not in published proceedings)

Morrin, H., Gunningham, S., Currie, M., Dachs, G., Fox, S., & Robinson, B. (2004, June). The Christchurch tissue bank: An investment in cancer research. Poster session presented at the New Zealand Society of Oncology Conference, Christchurch, New Zealand.

Conference Contribution - Verbal presentation and other Conference outputs

Morris, C., Benjes, S., Gough, S., McDonald, M., McKenzie, G., Moon, S. Y., Walker, L., Morrin, H., … Atkinson, C., Ganly, P., Harris, G., Miller, A. P., Robinson, B., & Spearing, R. (2004, June). Cancer genetics: Ar'ray for the future! Verbal presentation at the New Zealand Society for Oncology Conference, Christchurch, New Zealand.

2003

Journal - Research Article

Hanrahan, V., Currie, M., Gunningham, S. P., Morrin, H., Scott, P. A. E., Robinson, B. A., & Fox, S. B. (2003). The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. Journal of Pathology, 200(2), 183-194.

Conference Contribution - Published proceedings: Abstract

McCall, J., Bartlett, A., Koea, J., Thompson, P. I., & Robinson, B. (2003). Neoadjuvant systematic chemotherapy in patients with synchronous colorectalliver liver metastases. Proceedings of the New Zealand Society of Oncology Meeting. [Abstract]

Walker, L. C., Wells, J. E., Brunton, H., Robinson, B. A., Ellis, L., Sullivan, M. J., Atkinson, C., & Morris, C. M. (2003). Molecular profiling breast carcinomas by comparative genomic hybridisation of prospectively sampled core biopsies. Proceedings of the XIX International Congress of Genetics: Genomes, the linkage to life. (pp. 197). Melbourne: International Genetics Federation. [Abstract]

Walker, L. C., Wells, J. E., Brunton, H., Robinson, B. A., Ellis, L., Sullivan, M. J., Atkinson, C., & Morris, C. M. (2003). Molecular profiling breast carcinomas by comparative genomic hybridisation of prospectively sampled core biopsies. Proceedings of the New Zealand Society for Oncology Annual Scientific Meeting 2003: Into the new era. (pp. 64). Christchurch: NZSO. [Abstract]

2002

Journal - Research Article

Currie, M., Gunningham, S. P., Cheng, H., Robinson, B. A., Scott, P. A. E., Harris, A. L., & Fox, S. B. (2002). Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; Regulation by the von Hippel-Lindau gene and hypoxia. Journal of Pathology, 198, 502-510.

Gardiner, S. J., Begg, E. J., & Robinson, B. A. (2002). The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracil. Adverse Drug Reactions & Toxicological Reviews, 21(1-2), 1-16.

Joung, S., & Robinson, B. A. (2002). Venous thromboembolism in cancer patients in Christchurch, 1995- 1999. New Zealand Medical Journal, 115, 257-260.

Conference Contribution - Published proceedings: Abstract

Mouridsen, H., Harvey, V. J., Semiglazov, V., Voznyi, E., Robinson, B., Murawsky, M., & Haregewoin, A. (2002). Phase III study of docetaxel 100 versus 75 versus 60 mg/m² as second line chemotherapy in advanced breast cancer. Proceedings of the 25th Annual San Antonio Breast Cancer Symposium. [Abstract]

Fox, S. B., Gunningham, S. P., Hanrahan, V., Currie, M. J., Morrin, H. R., Scott, P. A. E., Robinson, B. A., & Wilson, W. R. (2002). 5,6-dimethylxanthenone-4-acetic acid may cause tumour infarction in WiDr xenograft model by up-regulating soluble neuropilin-1. Proceedings of the New Zealand Society of Oncology Meeting. [Abstract]

Currie, M., Gunningham, S. P., Hanrahan, V., Morrin, H., Scott, P. A. E., Robinson, B. A., & Fox, S. B. (2002). VEGF-D expression is associated with lymph node status in primary human breast carcinomas and regulated by estrogen in breast carcinoma cell lines. In F. A. Frizelle (Ed.), Proceedings of the Scientific Meeting and 32nd Annual General Meeting of the Christchurch Medical Research Society. 115(1157), (pp. 27). Christchurch: New Zealand Medical Journal. [Abstract]

Currie, M., Gunningham, S. P., Morrin, H., Robinson, B. A., Scott, P., & Fox, S. B. (2002). VEGF-D expression in primary human breast carcinomas is associated with lymph node status and is regulated by estrogen in T47D but not MCF-7 breast cell lines. Keystone Symposia 2002 Abstract book. Silverthorne, United States of America: Keystone Symposia. [Abstract]

Hanrahan, V., Currie, M., Gunningham, S. P., Morrin, H., Scott, P. A. E., Robinson, B. A., & Fox, S. B. (2002). Gene expression of VEGF-A, VEGF-B, VEGF-C and their tyrosine kinase receptors in human colorectal cancer. Proceedings of the Scientific meeting and 32nd Annual General meeting of the Christchurch Medical Research Society. 115(1157), (pp. 27). Christchurch: New Zealand Medical Journal. [Abstract]

2001

Journal - Research Article

Currie, M., Gunningham, S. P., Han, C., Scott, P. A. E., Robinson, B. A., Harris, A., & Fox, S. B. (2001). Angiopoietin-1 is inversely related to thymidine phosphorylase expression in human breast cancer, indicating a role in vascular remodeling. Clinical Cancer Research, 7(4), 918-927.

Gunningham, S. P., Currie, M. J., Han, C., Robinson, B. A., Scott, P. A. E., Harris, A. L., & Fox, S. B. (2001). VEGF-B expression in human primary breast cancers is associated with lymph node metastasis but not angiogenesis. Journal of Pathology, 193(3), 325-332.

Gunningham, S. P., Currie, M. J., Han, C., Turner, K. S., Scott, P. A. E., Robinson, B. A., … Fox, S. B. (2001). Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: Regulation by the von Hippel-Lindau gene and hypoxia. Cancer Research, 61(7), 3206-3211.

Conference Contribution - Published proceedings: Abstract

Currie, M., Gunningham, S. P., Turner, K., Cheng, H., Scott, P. A. E., Robinson, B. A., … Fox, S. B. (2001). Angiopoietin -2 expression in human renal clear cell carcinomas:Regualtion by the Von Hippel Lindau gene and hypoxia. Proceedings of XXXIV International Congress of Physiological Sciences. http://iups.mcw.edu: IUPA (International Union of Physiological Sciences. [Abstract]

Gunningham, S. P., Currie, M., Cheng, H., Turner, K., Scott, P., Robinson, B. A., … Fox, S. B. (2001). VEGF-B and VEGF-C expression in renal cell carcinomas: Regulation by the Von Hippel Lindau gene and hypoxia. In G. Nicholls (Ed.), Proceedings of the Christchurch Medical Research Society Meeting, April 2001. 114(1138), (pp. 385-386). Dunedin, New Zealand: New Zealand Medical Association. [Abstract]

Gunningham, S. P., Currie, M., Cheng, H., Turner, K., Scott, A. E., Robinson, B. A., … Fox, S. B. (2001). VEGF-B and VEGF-C expression in renal cell carcinomas: Regulation by the Von Hippel-Lindau gene and hypoxia. 2001 Proceedings of the American Association for Cancer Research. 42. AACR. [Abstract]

Conference Contribution - Verbal presentation and other Conference outputs

Joung, S., & Robinson, B. A. (2001, April). Venous thromboembolism in cancer patients in Christchurch, 1995- 1999. Verbal presentation at the New Zealand Society of Oncology

2000

Journal - Research Article

Gunningham, S. P., Currie, M. J., Han, C., Robinson, B. A., Scott, P. A. E., Harris, A. L., & Fox, S. B. (2000). The short form of the alternatively spliced flt-4 but not its ligand vascular endothelial growth factor C is related to lymph node metastasis in human breast cancers. Clinical Cancer Research, 6(11), 4278-4286.

Hanley, J. P., MacLean, F. R., Evans, J. L., Colls, B. M., Robinson, B. A., Patton, W. N., & Heaton, D. C. (2000). Hemorrhagic lymphadenopathy as a presenting feature of primary AL amyloidosis. Pathology, 32, 21-23.

Conference Contribution - Published proceedings: Abstract

Currie, M., Gunningham, S. P., Scott, P., Robinson, B. A., & Fox, S. B. (2000). Expression of Angiopoietin-1, Angiopoietin-2 & Tie 2 in kidney and breast carcinomas. In G. Nicholls (Ed.), Proceedings of the Scientific meeting of the Christchurch Medical Research Society. 113(1111), (pp. 231-232). Dunedin, New Zealand: New Zealand Medical Association. [Abstract]

1998

Journal - Research Article

Hutenburg, R. P., Turner, J. R., Mannering, D. M., & Robinson, B. A. (1998). Monte Carlo methods for the in vivo analysis of cisplatin using x-ray fluorescence. Applied Radiation & Isotopes, 49(5/6), 673-676.

Raizis, A., Ferguson, M. M., Robinson, B. A., Atkinson, C. H., & George, P. M. (1998). Identification of a novel PTEN mutation (L139X) in a patient with Cowden disease and Sjogren syndrome. Journal of Clinical Pathology, 51, 339-341.

Frizelle, F. A., Robinson, B. A., & McCall, J. L. (1998). The management of recurrent and metastatic colorectal adenocarcinoma. New Zealand Medical Journal, 111, 241-244.

1997

Journal - Research Article

Duffull, S. B., & Robinson, B. A. (1997). Clinical pharmacokinetics and dose optimisation of carboplatin. Clinical Pharmacokinetics, 33(3), 161-183.

Duffull, S. B., Begg, E. J., Robinson, B. A., & Deely, J. J. (1997). A sequential bayesian algorithm for dose individualisation of carboplatin. Cancer Chemotherapy & Pharmacology, 39(4), 317-326.

Sorg, U. R., Morse, T. M., Patton, W. N., Hock, B. D., Angus, H. B., Robinson, B. A., Colls, B. M., & Hart, D. N. J. (1997). Hodgkin's cells express CD83, a dendritic cell lineage associated antigen. Pathology, 29(3), 294-299. doi: 10.1080/00313029700169125